External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
Background & Aims: The Toronto hepatocellular carcinoma (HCC) risk index (THRI) is a predictive model to determine the risk of HCC in patients with cirrhosis. This study aimed to externally validate the THRI in a Swedish setting to investigate whether it could identify patients not requiring...
Main Authors: | Hanne Åström, Nelson Ndegwa, Hannes Hagström |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555921001191 |
Similar Items
-
Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study
by: Huixian Zhang, et al.
Published: (2019-04-01) -
Mixed hepatocellular carcinoma-neuroendocrine carcinoma—A diagnostic and therapeutic challenge
by: Nusrat Jahan, et al.
Published: (2020-12-01) -
Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01) -
Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01) -
Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis
by: Lior Charach, et al.
Published: (2017-06-01)